Evidence map›Paper›PMID 35275026›Full record

ArticleAutophagy2022

Iron chelation promotes mitophagy through SENP3-mediated deSUMOylation of FIS1.

Kevin A Wilkinson, Chun Guo

Open access · hybridAbstract readComment
In one paragraph

Article in Autophagy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kevin A WilkinsonSchool of Biochemistry, Medical Sciences Building, University of Bristol, University Walk, Bristol, U.K.ORCID 0000-0002-8115-8592
Chun GuoSchool of Biosciences, University of Sheffield, Firth Court, Western Bank, Sheffield, U.K.ORCID 0000-0002-1540-3166
University of Bristol · GBUniversity of Sheffield · GB

Funding

Biotechnology and Biological Sciences Research Council BB/R00787X
6 · The paper itself

Abstract

The selective clearance of mitochondria by mitophagy is an important quality control mechanism for maintaining mitochondrial and cellular health. Iron chelation, for example by the compound deferiprone (DFP), leads to a specific form of PINK1-PRKN/Parkin-independent mitophagy; however, the molecular mechanisms underlying this are poorly understood. In our recent paper, we examined the role of the deSUMOylating enzyme SENP3 in DFP-induced mitophagy. We observed that SENP3 levels are enhanced by DFP treatment, and that SENP3 is essential for DFP-induced mitophagy. Furthermore, we identified the mitochondrial protein FIS1, which is also required for DFP-induced mitophagy, as a novel SUMO substrate. Our data demonstrate that SENP3-dependent deSUMOylation of FIS1 enhances FIS1 mitochondrial targeting, to promote mitophagy in response to DFP treatment. These findings offer new insight into the mechanisms underlying mitophagy upon iron chelation, and have relevance to the therapeutic potential of DFP in a number of disorders, including Parkinson disease.

Indexed as

Cysteine EndopeptidasesMembrane ProteinsMitochondrial ProteinsMitophagyParkinson DiseaseAutophagyDeferiproneHumansIron Chelating AgentsProtein KinasesUbiquitin-Protein LigasesCysteine EndopeptidasesDeferiproneFIS1 protein, humanIron Chelating AgentsMembrane ProteinsMitochondrial ProteinsProtein KinasesSENP3 protein, humanUbiquitin-Protein LigasesFIS1iron chelationmitophagySENP3SUMO

Identifiers

PMID35275026
PMCPMC9298444
OpenAlexW4220907334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.